Skip to main content

Scientists Create a New Best-in-Class Anti-Malarial Antibody

Submitted by rileyta on November 17, 2021 - 09:10 AM

Just as monoclonal antibody treatment has been made available for COVID-19 patients, the US National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID), has completed a monoclonal antibody trial in preventing malaria. Malaria remains a critical health burden in sub-Saharan Africa, which some say has caused more deaths than the ongoing COVID-19 pandemic.

Content Source:


Content Author: